NASDAQ: SSKN - STRATA Skin Sciences, Inc.

Rentabilität für sechs Monate: +430.61%
Sektor: Healthcare

Aktionsplan STRATA Skin Sciences, Inc.


Über das Unternehmen

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions.

Weitere Details
It also provides TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Выручка 0.0299
EBITDA 0.0011
Число акций ао 0.03492 млрд
P/S 1.77
P/BV 1.7
EV/EBITDA 39.89
Цена ао 0.46
ISIN US86272A2069
Сайт https://www.strataskinsciences.com
Валюта usd
IPO date 2005-10-28
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Preisänderung pro Tag: -4.06% (2.71)
Preisänderung pro Woche: -18.75% (3.2)
Preisänderung pro Monat: -14.05% (3.0251)
Preisänderung über 3 Monate: -15.86% (3.0902)
Preisänderung über sechs Monate: +430.61% (0.49)
Preisänderung pro Jahr: +356.14% (0.57)
Preisänderung über 3 Jahre: +42.86% (1.82)
Preisänderung über 5 Jahre: +46.07% (1.78)
Preisänderung seit Jahresbeginn: +687.88% (0.33)

Unterschätzung

Name Bedeutung Grad
P/S 0.5883 10
P/BV 1.55 8
P/E 0 0
EV/EBITDA -64.93 0
Gesamt: 6

Effizienz

Name Bedeutung Grad
ROA, % -25.78 0
ROE, % -85.36 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -36.83 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 5.56 1
Rentabilität Ebitda, % -119 0
Rentabilität EPS, % 2517.17 10
Gesamt: 6.2

Institutionen Volumen Aktie, %
Nantahala Capital Management, LLC 6256264 17.84
22NW, LP 5369954 15.32
Renaissance Technologies, LLC 1067453 3.04
Vanguard Group Inc 858202 2.45
Cannell Capital LLC 275806 0.79
Geode Capital Management, LLC 110621 0.32
Creative Planning 100160 0.29
Perritt Capital Management, Inc. 100000 0.29
Blackrock Inc. 97436 0.28
We Are One Seven, LLC 71420 0.2



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Shmuel Gov Chief Operating Officer 490.44k 1960 (64 Jahr)
Dr. Dolev Rafaeli Ph.D. President, CEO & Vice-Chairman 408.71k 1964 (60 Jahre)
Mr. Jay Sturm General Counsel & Corporate Secretary N/A 1956 (68 Jahre)
Mr. Michael R. Stewart Independent Consultant 732.9k 1957 (67 Jahre)
Mr. John Gillings VP of Finance

Adresse: United States, Horsham. PA, 5 Walnut Grove Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.strataskinsciences.com